Description:
The NIH invites grant applications to support the development, standardization, and validation of novel approaches to obtain comprehensive absorption, distribution, metabolism, excretion (ADME) and toxicological (TOX) profiles that could better predict how new molecular entities will perform in humans to reduce the failure rate in clinical testing. This is an NIH Roadmap initiative. This funding opportunity will use the R21 Exploratory/Developmental Research Grants award mechanism. This RFA solicits applications that explore novel, high-risk, and high-impact approaches to achieve this goal, rather than incremental technology development that is already supported by current NIH programs.
Who can apply:
Anyone/General Public
City Or Township Governments
County Governments
Federally Recognized Indian Tribal Governments
Independent School Districts
Individual/Family
Minority Group
Native American Organization
Non-Government - General
Nonprofits Having A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Nonprofits That Do Not Have A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Other Private Institution/Organization
Private Institutions Of Higher Education
Private Nonprofit Institution/Organization (Includes Institutions Of Higher Education, Hospitals)
Profit Organization
Public And State Controlled Institutions Of Higher Education
Public Housing Authorities/Indian Housing Authorities
Quasi-Public Nonprofit Institution/Organization
Small Business (Less Than 500 Employees
Special District Governments
State (Includes District Of Columbia; Includes Institutions Of Higher Education And Hospitals)
U.S. Territories And Possessions (Includes Institutions Of Higher Education, Hospitals)
Eligible functional categories:
Funding Sources:
Biomedical Research and Research Training
More Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-04-023.html
If you have problems accessing the full announcement, please contact:
NIH OER Webmaster
Address Info: